Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

456.93 -6.55 (-1.41%)
Streaming Delayed Price Updated: 10:22 AM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
63 64 Next >
News headline image
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks ↗
The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program. 
Via Investor's Business Daily
Topics Government Intellectual Property
News headline image
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Rising Costs Weigh on Vertex Q1 Earnings ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Wondering what's happening in today's S&P500 pre-market session? ↗
Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
Earnings Scheduled For May 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Outlook For Vertex Pharmaceuticals ↗
 
Via Benzinga
News headline image
Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
This Vertex Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday ↗
 
Via Benzinga
News headline image
Vertex Pharma Stock’s Retail Buzz Intensifies As 2025 Revenue View Lift Fails To Offset Q1 Miss ↗
The company’s Q1 revenue missed expectations, but the company raised its 2025 revenue guidance, reflecting optimism about growth drivers like cystic fibrosis treatments and its expanding pipeline. 
Via Stocktwits
Topics World Trade
News headline image
Monday's after hours session: top gainers and losers in the S&P500 index ↗
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top S&P500 gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance ↗
Vertex Pharmaceuticals reports first-quarter financial results after the market close on Monday. Here's a look at the key highlights from the period. 
Via Benzinga
News headline image
Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Sales Below Analyst Estimates In Q1 Earnings
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of... 
Via StockStory
News headline image
Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum? ↗
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reports Q1 earnings with $4.32 EPS and $2.85B revenue. Stock up 25.48% in past year, charts show bullish trend. 
Via Benzinga
News headline image
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday? ↗
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services... 
Via Benzinga
News headline image
Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
 
Via Benzinga
News headline image
Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now ↗
Now may be a smart time to buy small stakes in these fundamentally robust companies. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
3 No-Brainer Stocks to Buy in May ↗
Via The Motley Fool
News headline image
5 Growth Stocks to Buy in May and Go Away ↗
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
News headline image
Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results tomorrow afternoon. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
S&P Global, Berkshire Hathaway, CME Group And A Health Care Stock: CNBC's 'Final Trades' ↗
 
Via Benzinga
Topics Stocks
News headline image
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Technical Breakout Potential ↗
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Technical Breakout Potential 
Via Chartmill
News headline image
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount ↗
Via The Motley Fool
News headline image
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom ↗
Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising... 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
My 5 Top Stocks to Buy Right Now in This Highly Volatile Market ↗
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday ↗
Via The Motley Fool
News headline image
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold ↗
Via The Motley Fool
Topics Government
News headline image
Expert Outlook: Vertex Pharmaceuticals Through The Eyes Of 18 Analysts ↗
 
Via Benzinga
News headline image
Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right ↗
Via The Motley Fool
Topics Economy Government World Trade
News headline image
Vertex Has A Lot Riding On Alyftrek, Journavx — And Investors Are Watching Closely ↗
Vertex Pharmaceuticals is expected to report first quarter earnings on May 5, with investor focus on its two big launches and potential upside surprises. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
63 64 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.